Sort by
Keyphrases
Mitogen-activated Protein Kinase
100%
Malignant Melanoma
100%
Systems Biology Analysis
100%
Inhibitor Resistance
100%
Mitogen-activated Protein Kinase Inhibitor
100%
Cellular Models
40%
Mechanistic Insight
40%
Treatment Resistance
40%
Resistant Cells
40%
BRAF mutation
40%
Tumor
20%
Cell Proliferation
20%
Cell Therapy
20%
Transcription Factor
20%
Amino Acids
20%
Tumor Suppressor
20%
Signaling Pathway
20%
RNA Sequencing (RNA-seq)
20%
Treatment-resistant
20%
Cancer Patients
20%
Systems Biology
20%
Blockage
20%
Differentially Expressed Genes
20%
Therapeutic Target
20%
Cognate Receptors
20%
Growth Hormone Receptor
20%
Hypoxia-inducible Factor
20%
Clinical Benefit
20%
Cytokine Receptor
20%
Expression Profiling
20%
Cell Metabolism
20%
Vemurafenib
20%
Drug Resistance
20%
Metastatic Potential
20%
Master Regulator
20%
Tumor Cell Survival
20%
Pigmentation
20%
Treatment Pathways
20%
PCR Array
20%
Melanoma Model
20%
Malignant Progression
20%
Cellular Changes
20%
Kinase Inhibition
20%
Redundant Signals
20%
Mitogenic Signaling
20%
Effector Genes
20%
One-carbon Metabolism
20%
Transcriptomic Expression
20%
A375
20%
Non-genomic
20%
SK-MEL-28
20%
Drug-resistant Cancer
20%
Clinical Relapse
20%
DUSP1
20%
Forkhead Box
20%
Melanogenesis
20%
Genomic Adaptation
20%
PLX4032
20%
Upstream Regulator Analysis
20%
Treatment Mechanisms
20%
Melanogenesis Pathway
20%
Vemurafenib-resistant
20%
Tumorigenic Effects
20%
BRAF Inhibitor (BRAFi)
20%
Inhibitor Treatment
20%
In Vitro Cell Models
20%
Transcriptional Plasticity
20%
Medicine and Dentistry
Melanoma
100%
Mitogen Activated Protein Kinase Inhibitor
100%
Mitogen-Activated Protein Kinase
100%
Vemurafenib
60%
Cellular Model
60%
Carcinogenesis
40%
Kinase Signaling
40%
Melanogenesis
40%
In Vitro
20%
Receptor
20%
Cytokine
20%
Transcriptomics
20%
Amino Acid
20%
Malignant Neoplasm
20%
down Regulation
20%
Cell Proliferation
20%
Cell Survival
20%
Tumor Cell
20%
Hypoxia Inducible Factor
20%
Upregulation
20%
Phosphotransferase
20%
Metastasis Potential
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
20%
Phosphatase
20%
Cell Cycle
20%
Cell Metabolism
20%
Pigmentation
20%
Carbon Metabolism
20%
Tumor
20%
Cell Signaling Pathway
20%
RNA Sequencing
20%
Kinase
20%
Transcription Factors
20%
Cell Line
20%
Growth Factor
20%
Drug Resistance
20%
Tumor Suppressor Protein
20%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Mitogen Activated Protein Kinase
100%
Mitogen Activated Protein Kinase Inhibitor
100%
Vemurafenib
60%
Malignant Neoplasm
40%
Carcinogenesis
40%
Growth Factor
20%
Receptor
20%
Cytokine
20%
Phosphotransferase
20%
Amino Acid
20%
Metastasis Potential
20%
Hypoxia Inducible Factor
20%
Tumor Suppressor Protein
20%
Transcription Factors
20%
Neoplasm
20%
Drug Resistance
20%
Phosphatase
20%
Biochemistry, Genetics and Molecular Biology
Mitogen-Activated Protein Kinase
100%
Vemurafenib
25%
Melanogenesis
25%
Carcinogenesis
25%
Amino Acids
12%
Tumor Suppressor Protein
12%
RNA Sequencing
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Cell Proliferation
12%
Transcriptomics
12%
Cell Cycle
12%
Cell Survival
12%
down Regulation
12%
Cell Metabolism
12%
Upregulation
12%
Hypoxia-Inducible Factors
12%
Carbon Metabolism
12%
Pigmentation
12%
Transcription Factors
12%
Phosphotransferase
12%
Kinase
12%
Cytokine
12%
Drug Resistance
12%
Growth Factor
12%
Genomics
12%
Phosphatase
12%
Differentially Expressed Gene
12%